May 24, 2017 / 6:27 AM / 3 months ago

BRIEF-Xbrane Biopharma announces a directed new share issue of SEK 20 million

May 24 (Reuters) - XBRANE BIOPHARMA AB:

* REG-XBRANE BIOPHARMA ANNOUNCES A DIRECTED NEW SHARE ISSUE OF SEK 20 MILLION

* NEW SHARE ISSUE IS CONDUCTED AS A DIRECTED ISSUE TO ACTIVE INVEST-SWEDEN AB, THOMAS EKLUND, ZIRKONA AB AND QUANTIFY AB

* SHARES ARE ISSUED AT A SUBSCRIPTION PRICE OF SEK 30.50 PER SHARE, WHICH MEANS THAT COMPANY WILL RECEIVE SEK 20 MILLION BEFORE TRANSACTION COSTS.

* DECIDED TO ISSUE A TOTAL OF 655,738 NEW SHARES IN XBRANE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below